https://www.selleckchem.com/products/cb1954.html
ve approach to categorize findings. The categories will be synthesized into a set of findings that can be applied as evidence-based practice. Anticoagulation with unfractionated heparin remains the most common therapy used to prevent circuit thrombosis during extracorporeal membrane oxygenation, but no consensus exists on the optimal method or targets for heparin monitoring. From 2015 to 2018, we switched from monitoring heparin during extracorporeal membrane oxygenation using activated clotting times to anti-Xa heparin activity assays.
Aimer
Commentaire
Partagez
